FIORCARI, STEFANIA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 3.299
EU - Europa 1.284
AS - Asia 433
SA - Sud America 7
OC - Oceania 3
AF - Africa 1
Continente sconosciuto - Info sul continente non disponibili 1
Totale 5.028
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.285
GB - Regno Unito 529
IT - Italia 234
SE - Svezia 161
CN - Cina 146
DE - Germania 130
SG - Singapore 126
HK - Hong Kong 76
UA - Ucraina 60
FI - Finlandia 51
TR - Turchia 46
BG - Bulgaria 28
FR - Francia 21
BE - Belgio 20
ID - Indonesia 14
CZ - Repubblica Ceca 12
CA - Canada 11
VN - Vietnam 9
RU - Federazione Russa 8
ES - Italia 7
JP - Giappone 6
RO - Romania 6
NL - Olanda 5
CL - Cile 4
AU - Australia 3
BZ - Belize 3
IE - Irlanda 3
IN - India 3
MY - Malesia 3
BR - Brasile 2
DK - Danimarca 2
HR - Croazia 2
IR - Iran 2
LT - Lituania 2
AM - Armenia 1
AR - Argentina 1
AT - Austria 1
DZ - Algeria 1
EU - Europa 1
GR - Grecia 1
PK - Pakistan 1
PL - Polonia 1
Totale 5.028
Salva come PNG Salva come JPEG
Città #
Fairfield 521
Southend 446
Woodbridge 294
Ashburn 275
Chandler 254
Houston 244
Cambridge 208
Seattle 205
Wilmington 155
Ann Arbor 151
Nyköping 133
Santa Clara 127
Dearborn 108
Modena 105
Jacksonville 102
Singapore 84
Hong Kong 76
New York 46
Fremont 42
Beijing 35
Helsinki 32
San Diego 30
Izmir 29
Princeton 29
Sofia 28
Bremen 26
Eugene 26
Brussels 20
Munich 20
London 18
Redwood City 15
Milan 14
Bologna 13
Jakarta 13
Frankfurt am Main 11
Falls Church 9
Phoenix 9
San Jose 9
Boardman 8
Brno 8
Dong Ket 8
San Giuliano Milanese 7
Castelnuovo Rangone 6
Chicago 6
Dallas 6
Des Moines 6
Madrid 6
Shanghai 6
Guangzhou 5
Hefei 5
Ottawa 5
Reggio Emilia 5
Kilburn 4
Kunming 4
Norwalk 4
San Francisco 4
Amsterdam 3
Atlanta 3
Belize City 3
Castelnovo ne' Monti 3
Clearwater 3
Dongguan 3
Dublin 3
Las Vegas 3
Leawood 3
Los Angeles 3
Parma 3
Toronto 3
Verona 3
Albuquerque 2
Ancona 2
Boretto 2
Chiswick 2
Constanta 2
Fasano 2
Freiburg 2
Fukushima 2
Fuzhou 2
Hounslow 2
Indiana 2
Jinan 2
Jinhua 2
Lappeenranta 2
Martina Franca 2
Montréal 2
Olomouc 2
Osimo 2
Saint Louis 2
Santiago 2
Shenyang 2
Southwark 2
São Paulo 2
Timisoara 2
Tokushima 2
Trento 2
Udine 2
Wandsworth 2
Wuhan 2
Zagreb 2
Athens 1
Totale 4.165
Salva come PNG Salva come JPEG
Nome #
Monocytic population in chronic lymphocytic leukemia shows altered composition and deregulation of genes involved in phagocytosis and inflammation 413
Idelalisib impairs T-cell-mediated immunity in chronic lymphocytic leukemia 252
The histone deacetylase inhibitor romidepsin synergizes with lenalidomide and enhances tumor cell death in T-cell lymphoma cell lines 244
Ibrutinib modifies the function of monocyte/macrophage population in chronic lymphocytic leukemia 232
Endothelin-1 promotes survival and chemoresistance in chronic lymphocytic leukemia B cells through eta receptor 220
Increased SHISA3 expression characterizes chronic lymphocytic leukemia patients sensitive to lenalidomide 215
Lenalidomide interferes with tumor-promoting properties of nurse-like cells in chronic lymphocytic leukemia 212
Mesenchymal progenitors expressing TRAIL induce apoptosis in sarcomas 208
Physical contact with endothelial cells through β1- and β2- integrins rescues chronic lymphocytic leukemia from spontaneous and drug-induced apoptosis and induces a peculiar gene expression profile on leukemic cells. 197
Targeting neoplastic B cells and harnessing microenvironment: the “double face” of ibrutinib and idelalisib 196
The expression of endothelin-1 in chronic lymphocytic leukemia is controlled by epigenetic mechanisms and extracellular stimuli. 194
ANGPT2 promoter methylation is strongly associated with gene expression and prognosis in chronic lymphocytic leukemia 193
Macitentan, a double antagonist of endothelin receptors, efficiently impairs migration and microenvironmental survival signals in chronic lymphocytic leukemia 181
Endothelium-mediated survival of leukemic cells and angiogenesis-related factors are affected by lenalidomide treatment in chronic lymphocytic leukemia 181
Angiopoietin-2 acts as a survival factor for chronic lymphocytic leukemia B cells throughout Tie-2 receptor engagement 180
The PI3-kinase delta inhibitor idelalisib (GS-1101) targets integrin-mediated adhesion of chronic lymphocytic leukemia (CLL) cell to endothelial and marrow stromal cells 178
Increased angiogenesis induced by chronic lymphocytic leukemia B cells is mediated by leukemia-derived Ang2 and VEGF. 177
Angiopoietin-2 plasma dosage predicts time to first treatment and overall survival in chronic lymphocytic leukemia. 175
Lenalidomide in chronic lymphocytic leukemia: The present and future in the era of tyrosine kinase inhibitors 163
Immunomodulatory effect of ibrutinib: Reducing the barrier against fungal infections 155
Overexpression of CD49d in trisomy 12 chronic lymphocytic leukemia patients is mediated by IRF4 through induction of IKAROS 154
Selective inhibition of PI3Kγ affects survival and proliferation of chronic lymphocytic leukemia B cells 150
INTERACTION BETWEEN ENDOTHELIUM AND CHRONIC LYMPHOCYTIC LEUKEMIA B-CELLS RESCUES FROM APOPTOSIS AND MODULATES GENE EXPRESSION PROFILE OF LEUKEMIC CELLS 141
Clinical heterogeneity of de novo 11q deletion chronic lymphocytic leukaemia: prognostic relevance of extent of 11q deleted nuclei inside leukemic clone. 137
BTK Inhibition Impairs the Innate Response Against Fungal Infection in Patients With Chronic Lymphocytic Leukemia 128
Indoleamine 2, 3-Dioxygenase 1 Mediates Survival Signals in Chronic Lymphocytic Leukemia via Kynurenine/Aryl Hydrocarbon Receptor-Mediated MCL1 Modulation 90
Casein kinase 1: A new tale of chronic lymphocytic leukemia (CLL) microenvironment 87
Casein kinase 1: A new tale of chronic lymphocytic leukemia (CLL) microenvironment 56
Totale 5.109
Salva come PNG Salva come JPEG
Categoria #
all - tutte 20.898
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 20.898
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020894 0 0 0 0 99 149 231 130 106 59 72 48
2020/20211.111 87 57 71 145 200 99 79 97 43 100 58 75
2021/2022628 52 55 49 28 22 57 26 32 62 56 119 70
2022/2023729 77 96 58 74 95 90 10 84 76 5 30 34
2023/2024450 15 19 27 56 80 49 41 65 6 7 35 50
2024/2025323 37 25 13 117 131 0 0 0 0 0 0 0
Totale 5.109